Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease; its cause is unknown, and it leads to notable health problems. Currently, only two drugs are recommended for IPF treatment. Although these drugs can mitigate lung function decline, neither can improve nor sta...
Main Authors: | Cheng-Wei Huang, Shih-Yi Lee, Chen-Xuan Du, Shao-Tung Wu, Yueh-Hsiung Kuo, Hui-Chun Ku |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332224001793 |
Similar Items
-
A novel caffeic acid derivative prevents angiotensin II-induced cardiac remodeling
by: Shih-Yi Lee, et al.
Published: (2023-06-01) -
Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation
by: Peng Liu, et al.
Published: (2020-02-01) -
Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation via TGF-β/Smad2/3 Pathway
by: Jintao Jiang, et al.
Published: (2020-05-01) -
Antifibrotic Mechanism of Piceatannol in Bleomycin-Induced Pulmonary Fibrosis in Mice
by: Hanjing Sheng, et al.
Published: (2022-06-01) -
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
by: Yang Miao, et al.
Published: (2023-03-01)